Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell engagers
Biotech
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Under the terms of the deal, InduPro could collect a total of up to $950 million, with Lilly also making an equity investment in the biotech.
Gabrielle Masson
Jan 7, 2026 3:52pm
Pfizer maps out $865M Cartography discovery deal
Jan 6, 2026 7:30am
Analyst deems Janux's stock spiral an 'overreaction'
Dec 2, 2025 11:14am
Third Arc Bio teams up with Adagene to create T-cell engagers
Nov 13, 2025 10:45am
Cullinan puts kibosh on 2 cancer assets amid autoimmune refocus
Nov 6, 2025 1:26pm
Boehringer's deal frenzy continues with $570M autoimmune pact
Nov 4, 2025 8:00am
